Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winfried Barchet

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Nature Reviews. Immunology|August 22, 2015
Translating nucleic acid-sensing pathways into therapiesTobias Junt, Winfried Barchet
Immunity|September 18, 2015
Exonuclease TREX1 also Has a Sweet ToothWinfried Barchet, Thomas Zillinger
Seminars in Immunology|July 2, 2005
Plasmacytoid dendritic cells--virus experts of innate immunityWinfried Barchet, Marina Cella, Marco Colonna
Immunologic Research|August 18, 2005
Plasmacytoid dendritic cells: in search of their niche in immune responsesWinfried Barchet, Amanda Blasius, Marina Cella, et al.
Current Opinion in Immunology|July 26, 2008
Accessing the therapeutic potential of immunostimulatory nucleic acidsWinfried Barchet, Vera Wimmenauer, Martin Schlee, et al.
Handbook of Experimental Pharmacology|December 12, 2007
RNA recognition via TLR7 and TLR8Veit Hornung, Winfried Barchet, Martin Schlee, et al.
Advances in Immunology|March 28, 2012
Nucleic acid adjuvants: toward an educated vaccineJasper G van den Boorn, Winfried Barchet, Gunther Hartmann
The Journal of Experimental Medicine|October 10, 2007
Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cellsAmanda L Blasius, Winfried Barchet, Marina Cella, et al.
Blood|April 7, 2005
The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAMKent S Boles, Winfried Barchet, Tom Diacovo, et al.
Oncotarget|February 22, 2018
NAB2 is a novel immune stimulator of MDA-5 that promotes a strong type I interferon responseAnne Oberson, Lorenzo Spagnuolo, Viola Puddinu, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Nature Reviews. Immunology|August 22, 2015
Translating nucleic acid-sensing pathways into therapiesTobias Junt, Winfried Barchet
Immunity|September 18, 2015
Exonuclease TREX1 also Has a Sweet ToothWinfried Barchet, Thomas Zillinger
Seminars in Immunology|July 2, 2005
Plasmacytoid dendritic cells--virus experts of innate immunityWinfried Barchet, Marina Cella, Marco Colonna
Immunologic Research|August 18, 2005
Plasmacytoid dendritic cells: in search of their niche in immune responsesWinfried Barchet, Amanda Blasius, Marina Cella, et al.
Current Opinion in Immunology|July 26, 2008
Accessing the therapeutic potential of immunostimulatory nucleic acidsWinfried Barchet, Vera Wimmenauer, Martin Schlee, et al.
Handbook of Experimental Pharmacology|December 12, 2007
RNA recognition via TLR7 and TLR8Veit Hornung, Winfried Barchet, Martin Schlee, et al.
Advances in Immunology|March 28, 2012
Nucleic acid adjuvants: toward an educated vaccineJasper G van den Boorn, Winfried Barchet, Gunther Hartmann
The Journal of Experimental Medicine|October 10, 2007
Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cellsAmanda L Blasius, Winfried Barchet, Marina Cella, et al.
Blood|April 7, 2005
The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAMKent S Boles, Winfried Barchet, Tom Diacovo, et al.
Oncotarget|February 22, 2018
NAB2 is a novel immune stimulator of MDA-5 that promotes a strong type I interferon responseAnne Oberson, Lorenzo Spagnuolo, Viola Puddinu, et al.
Pageof 8